Parathyroid hormone in the evaluation of hypercalcemia.
作者信息
Cusano Natalie E, Bilezikian John P
机构信息
Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
出版信息
JAMA. 2014;312(24):2680-1. doi: 10.1001/jama.2014.9195.
Abstract
摘要
相似文献
1
Parathyroid hormone in the evaluation of hypercalcemia.
JAMA. 2014;312(24):2680-1. doi: 10.1001/jama.2014.9195.
2
3
Parathyroidectomy in a hypercalcaemic patient with inappropriately normal plasma parathyroid hormone: an unusual way to arrive at the correct diagnosis.
Nephrol Dial Transplant. 2001 Jan;16(1):171-4. doi: 10.1093/ndt/16.1.171.
4
Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism.甲状旁腺切除术治疗三发性甲状旁腺功能亢进症时的术中甲状旁腺激素监测。
J Surg Res. 2019 Dec;244:77-83. doi: 10.1016/j.jss.2019.06.020. Epub 2019 Jul 4.
5
Parathyroid hormone radioimmunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy.
Ann Intern Med. 1987 Apr;106(4):559-60. doi: 10.7326/0003-4819-106-4-559.
6
Hyperparathyroidism: surgical problems.
Am J Surg. 1974 Dec;128(6):767-72. doi: 10.1016/0002-9610(74)90067-1.
7
Diagnosis of primary hyperparathyroidism.
Aust N Z J Surg. 1991 Oct;61(10):730-1.
8
Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism.
Am J Med. 1991 Nov;91(5):547-8. doi: 10.1016/0002-9343(91)90193-2.
9
Evaluation of hyperparathyroidism through a reference laboratory.
Mo Med. 1975 Nov;72(11):645-9.
10
Decision-making in surgery: the surgical management of a raised serum calcium.
Br J Hosp Med. 1995;53(7):330-3.
引用本文的文献
1
Analysis of Time to Diagnosis and Outcomes Among Adults With Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症成年人的诊断时间和结局分析。
JAMA Netw Open. 2022 Dec 1;5(12):e2248332. doi: 10.1001/jamanetworkopen.2022.48332.
本文引用的文献
1
The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.无症状原发性甲状旁腺功能亢进的手术治疗：第四届国际研讨会论文集。
J Clin Endocrinol Metab. 2014 Oct;99(10):3595-606. doi: 10.1210/jc.2014-2000. Epub 2014 Aug 27.
2
Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的医学管理：无症状原发性甲状旁腺功能亢进管理第四次国际研讨会会议录。
J Clin Endocrinol Metab. 2014 Oct;99(10):3607-18. doi: 10.1210/jc.2014-1417. Epub 2014 Aug 27.
3
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.无症状原发性甲状旁腺功能亢进症的当前问题：第四届国际研讨会会议记录
J Clin Endocrinol Metab. 2014 Oct;99(10):3580-94. doi: 10.1210/jc.2014-1415. Epub 2014 Aug 27.
4
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.无症状原发性甲状旁腺功能亢进症的诊断：第四届国际研讨会会议录。
J Clin Endocrinol Metab. 2014 Oct;99(10):3570-9. doi: 10.1210/jc.2014-1414. Epub 2014 Aug 27.
5
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.无症状原发性甲状旁腺功能亢进症管理指南：第四届国际研讨会总结声明
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9. doi: 10.1210/jc.2014-1413. Epub 2014 Aug 27.
6
Falsely low parathyroid hormone secondary to biotin interference: a case series.假性低甲状旁腺激素继发于生物素干扰：病例系列研究。
Endocr Pract. 2013 May-Jun;19(3):451-5. doi: 10.4158/EP12158.OR.
7
Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans.
J Clin Endocrinol Metab. 1990 Aug;71(2):370-8. doi: 10.1210/jcem-71-2-370.
Zotero 插件